DIA435.72-5.61 -1.27%
SPX6,238.01-101.38 -1.60%
IXIC20,650.13-472.32 -2.24%

12 Health Care Stocks Moving In Thursday's Pre-Market Session

Benzinga·07/17/2025 12:08:10
Listen to the news

Gainers

  • Windtree Therapeutics (NASDAQ:WINT) shares increased by 56.7% to $1.41 during Thursday's pre-market session. The market value of their outstanding shares is at $8.3 million.
  • Sarepta Therapeutics (NASDAQ:SRPT) stock rose 29.81% to $23.86. The market value of their outstanding shares is at $1.8 billion.
  • Liminatus Pharma (NASDAQ:LIMN) shares increased by 14.81% to $6.2. The company's market cap stands at $140.4 million.
  • Marker Therapeutics (NASDAQ:MRKR) stock increased by 13.12% to $1.81. The company's market cap stands at $17.1 million.
  • Rocket Pharmaceuticals (NASDAQ:RCKT) shares increased by 9.79% to $3.14. The market value of their outstanding shares is at $308.1 million.
  • Harvard Bioscience (NASDAQ:HBIO) stock rose 8.64% to $0.44. The company's market cap stands at $17.9 million.

Losers

  • MEI Pharma (NASDAQ:MEIP) shares decreased by 17.4% to $3.19 during Thursday's pre-market session. The market value of their outstanding shares is at $25.7 million.
  • OKYO Pharma (NASDAQ:OKYO) shares decreased by 11.49% to $2.62. The company's market cap stands at $110.7 million.
  • Nuwellis (NASDAQ:NUWE) stock declined by 10.98% to $14.2. The company's market cap stands at $69.7 million.
  • Aptorum Group (NASDAQ:APM) stock fell 10.83% to $1.73. The market value of their outstanding shares is at $13.8 million.
  • Jade Biosciences (NASDAQ:JBIO) shares fell 9.2% to $8.0. The market value of their outstanding shares is at $463.4 million.
  • Kairos Pharma (AMEX:KAPA) stock decreased by 8.23% to $1.0. The company's market cap stands at $18.3 million. See Also: www.benzinga.com/money/best-healthcare-stocks/

This article was generated by Benzinga's automated content engine and reviewed by an editor.

Risk Disclosure: The content of this page is not an investment advice and does not constitute any offer or solicitation to offer or recommendation of any investment product. It is for general purposes only and does not take into account your individual needs, investment objectives and specific financial circumstances. All investments involve risk and the past performance of securities, or financial products does not guarantee future results or returns. Keep in mind that while diversification may help spread risk it does not assure a profit, or protect against loss, in a down market. There is always the potential of losing money when you invest in securities, or other financial products. Investors should consider their investment objectives and risks carefully before investing. For more details, please refer to risk disclosure.
Webull Securities Limited is licensed with the Securities and Futures Commission of Hong Kong (CE No. BNG700) for carrying out Type 1 License for Dealing in Securities, Type 2 License for Dealing in Futures Contracts and Type 4 License for Advising on Securities.
Language

English

©2025 Webull Securities Limited. All rights reserved.